Ente Ospedaliero Cantonale, Bellinzona
Clinical trials sponsored by Ente Ospedaliero Cantonale, Bellinzona, explained in plain language.
-
Could a treatment switch cut infection risk in MS patients?
Disease control OngoingThis study looks at whether switching from anti-CD20 drugs (like ocrelizumab) to cladribine can improve immune function and lower infection risk in people with relapsing multiple sclerosis. About 70 participants will be followed for 2 years. The goal is to see if the switch helps…
Sponsor: Ente Ospedaliero Cantonale, Bellinzona • Aim: Disease control
Last updated May 17, 2026 09:04 UTC
-
New combo therapy aims to ease knee pain without surgery
Symptom relief OngoingThis study tests whether combining blood flow restriction with anti-gravity treadmill walking is more effective than treadmill alone for knee osteoarthritis. About 70 adults aged 45-80 with confirmed knee OA will participate. The goal is to reduce pain, stiffness, and improve fun…
Phase: NA • Sponsor: Ente Ospedaliero Cantonale, Bellinzona • Aim: Symptom relief
Last updated May 12, 2026 13:42 UTC